Uji Klinis Propolis Brazil Tahap 3 Untuk Pasien Covid-19

Uji Klinis Propolis Brazil Tahap 3 Untuk Pasien Covid-19

Sebuah harapan baru datang dari Brazil, negeri penyuplai Propolis terbaik dunia. Semenjak Covid-19 mewabah di akhir tahun 2019, sejumlah peneliti Propolis Brazil melakukan serangkaian penelitian apakah Propolis Brazil yang terkenal sebagai obat alternative anti virus bisa bekerja melawan virus SARS-Cov-2 penyebab penyakit Covid-19 ?

Ada penelitian difokuskan ke antivirus, ada juga difokuskan untuk meneliti penghambat virus menempel ke sel. Penelitian lain nya difokuskan ke immumodulator. Selain itu, sejumlah penelitian diarahkan apakah Propolis Brazil efetif mencegah serangan Badai Sitokin, dan juga apakah Propolis Brazil bisa mencegah darah membeku akibat Covid-19.

Nah, penelitian-penelitian ini membawa berita gembira, ternyata Propolis Brazil bersifat antivirus, menghambat replikasi, selain itu juga mencegah virus menempel ke dinding sel. Dengan demikian, dengan dosis yang besar, maka virus Covid-19, akan sulit menempel ke dinding sel dan mereplikasi diri. Selain itu, Propolis Brazil ternyata mencegah inflamasi akibat Badai Sitokin, mencegah darah membeku dan meningkatkan daya tahan tubuh. Nah, Ayo… jangan tunggu sampai sakit, minum Propolis…. Namun jangan sembarang propolis, pastikan hanya Propolis Asli Brazil…

Reference :

1. The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19. (Bee-Covid),
D’Or Institute for Research and Education, Collabolator San Rafael Hospital, Brazil,
NIH U.S National Library of Medicine – ClinicalTrials.gov
Brief Summary:
Update date : 21 Juli 2020
The COVID-19 pandemic is of grave concern due its impact on human health and on the economy. Propolis, a natural resin produced by bees from plant materials, has anti-inflammatory, immunomodulatory, anti-oxidant properties, and various aspects of the SARS-CoV-2 infection mechanism are potential targets for propolis compounds. Propolis components have inhibitory effects on the ACE2, TMPRSS2 and PAK1 signaling pathways; in addition, antiviral activity has been proven in vitro and in vivo. This is a pilot randomized study that aims to assess the impact of using Brazilian green propolis extract against the deleterious effects of the new coronavirus.

2. Propolis and coronavirus disease 2019 (COVID-19): Lessons from nature
Complement Ther Clin Pract. 2020 Nov; 41: 101227.
Published online 2020 Aug 9. doi: 10.1016/j.ctcp.2020.101227

3. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease
Andresa AparecidaBerrettaaMarcelo AugustoDuarte SilveirabJosé ManuelCóndor CapchacDavidDe Jongd
Biomedicine & Pharmacotherapy
Available online 17 August 2020, 110622
In Press, Journal Pre-proofWhat are Journal Pre-proof articles?

4. Propolis anti-viral activity towards CODIV-19: is it effective?
Preprint (PDF Available) · March 2020 with 3,386 Reads
DOI: 10.13140/RG.2.2.22635.3664